BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Luo M, Zhou B, Hou J, Jiang D. Biomarkers for predicting nucleos(t)ide analogs discontinuation and hepatitis B virus recurrence after drug withdrawal in chronic hepatitis B patients. Hepatol Res 2022;52:337-51. [PMID: 35089634 DOI: 10.1111/hepr.13749] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Yun B, Ahn SH, Oh J, Yoon JH, Kim BK. Post-operative recurrence of liver cancer according to antiviral therapy for detectable hepatitis B viremia: A nationwide study. Eur J Intern Med 2023;107:66-72. [PMID: 36347739 DOI: 10.1016/j.ejim.2022.10.026] [Reference Citation Analysis]
2 Yun B, Oh J, Ahn SH, Yoon JH, Kim BK. Comparable Mortality Between Asian Patients with Chronic Hepatitis B Under Long-Term Antiviral Therapy vs Matched Control: A Population-Based Study. Am J Gastroenterol 2022. [PMID: 36288330 DOI: 10.14309/ajg.0000000000002074] [Reference Citation Analysis]
3 Chang M, Chien R, Liaw Y. Evidence-Based Management of Oral Nucleos(t)ide Analogue Withdrawal in Virally Suppressed Patients with Chronic HBV Infection. Curr Hepatology Rep 2022. [DOI: 10.1007/s11901-022-00587-z] [Reference Citation Analysis]